BMRN vs GLXY · P/E 40, rev $1.76B vs P/E 37, rev $60.41B
Biomarin Pharmaceutical Inc (BMRN) versus Galaxy Digital Holdings Ltd (GLXY) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Galaxy Digital Holdings Ltd (GLXY) is a capital markets company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported GLXY revenue for 2025-12-31 was $60.41B. Net income was -$241.3M. Revenue was up 41.8% from 2024-12-31 to 2025-12-31. GLXY currently screens at market cap $7.77B and trailing P/E 36.7.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GLXY currently screens at market cap $7.77B and trailing P/E 36.7.
Not investment advice. Open the BMRN and GLXY stock pages for the full models.
Not investment advice.